Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nat Commun. 2016 06 28; 7:11906.

View in: PubMed